The division of neonatology, Pediatric department, Faculty of medicine, Alexandria University, Alexandria, Egypt.
Radiodoagnosis and intervention department, Faculty of medicine, Alexandria University, Alexandria, Egypt.
Ital J Pediatr. 2024 Aug 13;50(1):147. doi: 10.1186/s13052-024-01708-8.
BACKGROUND: Central venous catheters (CVCs) are the major risk factors for neonatal thrombosis that might negatively affect morbidity and mortality in neonates. The aim of the present work was to estimate the incidence of CVC-linked thrombosis, among neonates in the NICU of Alexandria University Maternity Hospital, Egypt, over 1year, and to determine its possible risk factors. METHODS: This observational cohort study involved 134 newborn infants born from July 2020 to July 2021with CVCs insertion during their hospital stay. Patients who had congenital anomalies, had thrombosis unrelated to the implantation of CVCs or died before 7 days of catheter placement were excluded from the analysis. The 134 neonates who met the study's eligibility requirements had 142 CVCs inserted. Serial ultrasound and Doppler scans on site of venous insertion of catheters were performed. RESULTS: Seventeen patients with catheter's thrombosis (12%) were found during the placement of 142 catheters or 1615 CVCs' days, resulting in an overall rate of 10.5 thrombotic events per 1000 catheters' days. We constructed a logistic regression model to identify risk factors behind CVC-linked thrombosis. In univariate analysis, femoral central venous lines (CVLs), catheter dwell-time, sepsis, packed red cells (PRBCs) transfusions and low platelet count were risk factors for CVC-linked thrombosis. Nevertheless, only PRBCs transfusion was significant in the multivariate analysis, with OR and 95% confidence level 5.768 (1.013-32.836). CONCLUSION: Many factors should be considered in prediction of patients at risk of thrombosis including sepsis, femoral line insertion, low platelet count and PRBCs-transfusions. In our analysis, PRBCs-transfusion through peripheral intravenous lines (PIVs) was the strongest factor associated with CVC-linked thrombosis.
背景:中心静脉导管(CVC)是新生儿血栓形成的主要危险因素,可能会对新生儿的发病率和死亡率产生负面影响。本研究的目的是评估 1 年内埃及亚历山大大学妇产医院新生儿重症监护病房(NICU)中与 CVC 相关的血栓形成发生率,并确定其可能的危险因素。
方法:这是一项观察性队列研究,纳入了 2020 年 7 月至 2021 年 7 月期间在住院期间插入 CVC 的 134 名新生儿。排除了患有先天性异常、与 CVC 植入无关的血栓形成或在导管放置 7 天前死亡的患者。符合研究纳入标准的 134 名新生儿共插入 142 根 CVC。对导管静脉插入部位进行了连续的超声和多普勒扫描。
结果:在放置 142 根导管或 1615 根 CVC 日期间,发现 17 例患者导管血栓形成(12%),导致总血栓形成事件发生率为每 1000 根导管日 10.5 例。我们构建了一个逻辑回归模型来确定与 CVC 相关的血栓形成背后的危险因素。在单因素分析中,股静脉中央导管(CVL)、导管留置时间、败血症、红细胞(PRBC)输注和血小板计数低是与 CVC 相关的血栓形成的危险因素。然而,只有 PRBC 输注在多变量分析中具有统计学意义,OR 值和 95%置信区间为 5.768(1.013-32.836)。
结论:在预测血栓形成风险的患者时,应考虑许多因素,包括败血症、股静脉置管、血小板计数低和 PRBC 输注。在我们的分析中,通过外周静脉置管(PIV)输注 PRBC 是与 CVC 相关的血栓形成最强的相关因素。
Ital J Pediatr. 2024-8-13
Infect Control Hosp Epidemiol. 1991-9
J Pediatr Hematol Oncol. 2018-3
J Pediatr Surg. 2018-7
Ital J Pediatr. 2021-7-1
J Infus Nurs. 2021
J Pediatr Hematol Oncol. 2018-3